News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
136,798 Results
Type
Article (5202)
Company Profile (90)
Press Release (131506)
Multimedia
Podcasts (22)
Webinars (6)
Section
Business (43697)
Career Advice (209)
Deals (6445)
Drug Delivery (21)
Drug Development (19256)
Employer Resources (18)
FDA (1738)
Job Trends (2989)
News (69883)
Policy (4082)
Tag
Academia (305)
Accelerated approval (1)
Adcomms (24)
Allergies (16)
Alliances (12022)
ALS (31)
Alzheimer's disease (431)
Antibody-drug conjugate (ADC) (155)
Approvals (1724)
Artificial intelligence (65)
Autoimmune disease (13)
Automation (4)
Bankruptcy (47)
Best Places to Work (2471)
BIOSECURE Act (15)
Biosimilars (12)
Biotechnology (86)
Bladder cancer (30)
Brain cancer (7)
Breast cancer (132)
Cancer (873)
Cardiovascular disease (23)
Career advice (199)
Career pathing (5)
CAR-T (74)
Cell therapy (198)
Cervical cancer (10)
Clinical research (15679)
Collaboration (319)
Compensation (128)
Complete response letters (5)
COVID-19 (490)
CRISPR (14)
C-suite (118)
Cystic fibrosis (28)
Data (754)
Denatured (1)
Depression (10)
Diabetes (62)
Diagnostics (725)
Digital health (1)
Diversity, equity & inclusion (8)
Drug discovery (47)
Drug pricing (11)
Drug shortages (3)
Duchenne muscular dystrophy (23)
Earnings (13458)
Editorial (7)
Employer resources (18)
Events (26138)
Executive appointments (291)
FDA (2056)
Frontotemporal dementia (6)
Funding (245)
Gene editing (30)
Generative AI (5)
Gene therapy (96)
GLP-1 (131)
Government (401)
Guidances (38)
Healthcare (1863)
Huntington's disease (6)
IgA nephropathy (11)
Immunology and inflammation (28)
Indications (11)
Infectious disease (522)
Inflammatory bowel disease (55)
Inflation Reduction Act (3)
Influenza (18)
Intellectual property (38)
Interviews (18)
IPO (3074)
IRA (7)
Job creations (686)
Job search strategy (185)
Kidney cancer (2)
Labor market (9)
Layoffs (51)
Legal (657)
Liver cancer (14)
Lung cancer (113)
Lymphoma (78)
Machine learning (2)
Management (4)
Manufacturing (109)
MASH (11)
Medical device (421)
Medtech (421)
Mergers & acquisitions (3566)
Metabolic disorders (140)
Multiple sclerosis (26)
NASH (2)
Neurodegenerative disease (21)
Neuropsychiatric disorders (6)
Neuroscience (571)
NextGen: Class of 2025 (895)
Non-profit (283)
Now hiring (6)
Obesity (67)
Opinion (50)
Ovarian cancer (45)
Pain (25)
Pancreatic cancer (32)
Parkinson's disease (43)
Partnered (4)
Patents (64)
Patient recruitment (40)
Peanut (12)
People (16802)
Pharmaceutical (12)
Phase I (6227)
Phase II (7395)
Phase III (4001)
Pipeline (442)
Policy (32)
Postmarket research (226)
Preclinical (2653)
Press Release (51)
Prostate cancer (29)
Psychedelics (14)
Radiopharmaceuticals (68)
Rare diseases (83)
Real estate (1482)
Recruiting (10)
Regulatory (3442)
Reports (13)
Research institute (314)
Resumes & cover letters (20)
Rett syndrome (1)
RNA editing (1)
RSV (5)
Schizophrenia (13)
Series A (49)
Series B (33)
Service/supplier (2)
Sickle cell disease (13)
Special edition (3)
Spinal muscular atrophy (37)
Sponsored (4)
Startups (1012)
State (1)
Stomach cancer (9)
Supply chain (20)
Tariffs (8)
The Weekly (21)
Vaccines (99)
Venture capitalists (9)
Weight loss (26)
Women's health (5)
Worklife (2)
Date
Today (30)
Last 7 days (290)
Last 30 days (975)
Last 365 days (9690)
2025 (3564)
2024 (10179)
2023 (10773)
2022 (12896)
2021 (13394)
2020 (10430)
2019 (7039)
2018 (5564)
2017 (6334)
2016 (5806)
2015 (6615)
2014 (5073)
2013 (4175)
2012 (4512)
2011 (4950)
2010 (4570)
Location
Africa (146)
Alabama (33)
Alaska (1)
Arizona (27)
Arkansas (2)
Asia (9537)
Australia (2034)
California (2181)
Canada (597)
China (227)
Colorado (31)
Connecticut (82)
Delaware (53)
Europe (19714)
Florida (208)
Georgia (29)
Idaho (10)
Illinois (150)
India (6)
Indiana (104)
Iowa (1)
Japan (62)
Kansas (12)
Kentucky (2)
Louisiana (2)
Maine (2)
Maryland (248)
Massachusetts (1633)
Michigan (71)
Minnesota (99)
Missouri (10)
Montana (8)
Nebraska (2)
Nevada (6)
New Hampshire (5)
New Jersey (492)
New Mexico (6)
New York (534)
North Carolina (292)
North Dakota (4)
Northern California (992)
Ohio (39)
Oklahoma (5)
Oregon (5)
Pennsylvania (413)
Puerto Rico (3)
Rhode Island (5)
South America (209)
South Carolina (1)
Southern California (820)
Tennessee (15)
Texas (260)
United States (7153)
Utah (18)
Virginia (13)
Washington D.C. (8)
Washington State (341)
Wisconsin (8)
136,798 Results for "adc biotechnology".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Adcendo ApS to Present Data on its Clinical Stage ADCs ADCE-T02 and ADCE-D01 at the 2025 American Association for Cancer Research (AACR) Annual Meeting
April 24, 2025
·
4 min read
Press Releases
Iksuda to Present Growing ADC Pipeline at AACR
April 25, 2025
·
4 min read
Press Releases
CStone Presents Preclinical Results of CS2011 (EGFR/HER3 bispecific antibody), CS5007 (EGFR/HER3 bispecific ADC), CS5005 (SSTR2 ADC) and CS5006 (ITGB4 ADC) at 2025 AACR
May 7, 2025
·
10 min read
Antibody-drug conjugate
Next-Gen ADCs Driving ‘Renaissance’ in Already Hot Oncology Drug Class
ADC Therapeutics, Sutro Biopharma and Zai Lab are among those developing antibody-drug conjugates to address payload and toxicity challenges of current ADCs—and rapidly grow the multibillion-dollar market.
November 25, 2024
·
7 min read
·
Greg Slabodkin
IPO
Swiss ADC Biotech Takes SPAC Track to NASDAQ
The deal is a blast from the not-too-distant past, when special purpose acquisition companies were an easy way for companies to list on the public market with a bundle of cash to operate on.
April 23, 2025
·
1 min read
·
Annalee Armstrong
Antibody-drug conjugate
Gilead Plots ADC Comeback With Potential $415M License Agreement
The deal with Tubulis will help Gilead regain its footing in the ADC space following the withdrawal of Trodelvy in bladder cancer and its late-stage fail in NSCLC.
December 3, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Synthetic Design Lab Emerges with $20M to Advance Next-Generation ADCs
April 24, 2025
·
5 min read
Press Releases
BioDlink Applauds Junshi Biosciences on IND Approval of Bispecific ADC Candidate JS212
May 9, 2025
·
1 min read
Press Releases
LOTTE BIOLOGICS Begins Full-Scale Operation of ADC Manufacturing Facility
April 24, 2025
·
3 min read
Press Releases
Adcentrx Therapeutics Granted Fast Track Designation for ADRX-0706 Nectin-4 ADC for the Treatment of Advanced Cervical Cancer
May 7, 2025
·
4 min read
1 of 13,680
Next
